Company Filing History:
Years Active: 2008
Title: Mvong-Suk Ko: Innovator in Pharmaceutical Compounds
Introduction
Mvong-Suk Ko is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that enhance kinase activity.
Latest Patents
Mvong-Suk Ko holds a patent for 4,5,6,7-tetrahydro-[1,2]dithiolo[4,3-C] pyridine-3-thione compounds. This invention relates to new compounds that directly increase the kinase activity of p90 ribosomal S6 kinase 1 (RSK1). The patent also includes a pharmaceutical composition comprising these compounds as active ingredients. The use of this composition is aimed at preventing or treating hepatic fibrosis or cirrhosis. Furthermore, the patent outlines a method for administering a therapeutically effective amount of the composition to mammals for the treatment of these conditions.
Career Highlights
Mvong-Suk Ko is currently associated with CJ Cheiljedang Corporation, where he continues to innovate in the pharmaceutical sector. His work has the potential to impact the treatment of liver diseases significantly.
Collaborations
Some of his notable coworkers include Sang-Geon Kim and Seung-Jin Lee, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Mvong-Suk Ko's innovative work in pharmaceutical compounds showcases his commitment to advancing medical science. His contributions are vital for developing treatments for serious health conditions.